(CNN)– The Food and Drug Administration (FDA) wants suicide warnings to be taken off of some popular weight-loss medications. The affected products include Eli Lilly’s Zepbound, and Novo Nordisk’s Wegovy and Saxenda. The request follows an FDA review that found no increased risk of su icidal thoughts or behavior with the use of the GLP-1 medications. GLP-1 drugs were first approved to treat type-two diabetes, but they have gained in popularity since being approved for obesity in recent years. Categories: News Tags: Eli Lilly, FDA, Food and Drug Administration, GLP-1 weight loss drugs, Novo Nordisk, saxenda, U.S. Food and Drug Administration, Wegovy, weight loss, weight loss drugs, Zepbound ...read more read less